Increased lipid content has been observed in human pancreatic cancer and cell lines due to an increase in fatty acid synthase (FASN) expression which causes chemoresistance to gemcitabine, a widely used drug for the treatment of pancreatic cancer. Here, FASN is linked to pancreatic neoplasm.